|
|
Delivering Insulin: the Current Market and the Next Generation Quantity in Basket: None
Code: DVIN10J6
Price: $3,850.00
In spite of – and perhaps because of - the collapse of the inhaled insulin market in 2008, programs focused on alternative insulin delivery technologies continue to move forward. All of these numerous development-stage programs share the common goal of reaping commercial success by creating patient-friendly insulin delivery methods that address the preference and compliance issues associated with traditional injection methods. The market for insulin will grow significantly as the rate of increase in the number of patients diagnosed with both Type I and Type II diabetes grows worldwide. Over the next six years, injection and other parenteral insulin delivery products will have to compete with emerging insulin delivery methods – methods that will include pulmonary, intranasal, transdermal and oral insulin delivery. Each of these alternative delivery methods will be competing to take market share away from traditional insulin delivery methods, which will come under escalating pressure as new delivery systems are approved and commercialized.